Source: International Congress 2017 – Lung function testing



Rating:

Share or cite this content

Citations should be made in the following way:
T. Schreder (Bern, Switzerland). Nitrogen multiple breath washout indices as potentially prognostic markers in idiopathic pulmonary fibrosis. 2218

Member's Comments

No comment yet.

Related content which might interest you: A simple assessment of dyspnea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 37: 476 Year: 2011 Correlation between physical activity and prognostic markers in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 36: 1067-1072 Year: 2010 NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017 Year: 2017 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (3) 00019-2016; 10.1183/23120541.00019-2016 Year: 2017 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Nitrogen multiple breath washout test for infants with cystic fibrosis Source: Eur Respir J, 52 (2) 1800015; 10.1183/13993003.00015-2018 Year: 2018 Predictive systemic biomarkers of pulmonary fibrosis after COVID-19 pneumonia Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Correlation of composite physiologic index with 6-minute walk test variables in patients with idiopathic interstitial pneumonias Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007 Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Idiopathic pulmonary fibrosis: independent physiologic variables in the prediction of survival Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis Year: 2007 Validation of a novel prognostic tool for idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Inflammatory markers in cystic fibrosis patients with different values of pulmonary function tests Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 Comparison of clinical characteristics and prognostic factors between combined pulmonary fibrosis and emphysema/UIP versus non-UIP Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 The effect of spirometry on multiple breath washout outcomes in children with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018